Speed Up Access To Cancer Drugs, Australia's Senate Tells Government
This article was originally published in Scrip
An Australian Senate committee has called on the government to carry out a comprehensive review of the systems for drug approval and reimbursement listing in order to help speed up the availability and affordability of new innovative cancer medicines.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.